Nephros, Inc.
NEPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $74 | -$1,575 | -$4,553 | -$3,867 |
| Dep. & Amort. | $137 | $214 | $351 | $252 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $153 | $1,052 | $952 | $1,259 |
| Change in WC | -$1,554 | $488 | $229 | $883 |
| Other Non-Cash | $698 | $648 | -$213 | $56 |
| Operating Cash Flow | -$492 | $827 | -$3,234 | -$1,417 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$55 | -$75 | -$137 | -$36 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $5 | $0 | $0 | -$49 |
| Investing Cash Flow | -$50 | -$75 | -$137 | -$85 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$79 | -$286 | -$264 |
| Stock Issued | $0 | $0 | $163 | $501 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $157 | $0 |
| Financing Cash Flow | -$5 | -$79 | $34 | $237 |
| Forex Effect | $0 | $0 | -$2 | -$11 |
| Net Chg. in Cash | -$547 | $673 | -$3,339 | -$1,276 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,307 | $3,634 | $6,973 | $8,249 |
| End Cash | $3,760 | $4,307 | $3,634 | $6,973 |
| Free Cash Flow | -$547 | $752 | -$3,371 | -$1,453 |